Trial intelligence / Profile preview

ICX-RHY-013 for Remodeling Scar Contractures

NCT01564407Phase 2Terminated

Sponsor
University of Pittsburgh
Start
Jan 2011
Primary completion
Feb 2014
Modality
Tissue Cells
Countries
1
01

Overview

A Phase 2 trial of ICX-RHY-013 in scar contracture, burn scar, sponsored by University of Pittsburgh. Started Jan 2011; status: terminated.

02

Drugs

ICX-RHY-013
03

Conditions

scar contractureburn scar

Beyond the preview

Go deeper on NCT01564407.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01564407.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call